Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3

BACKGROUND: Galectin-3 (Gal-3) is a promising target in cancer therapy with a high therapeutic potential due to its abundant localization within the tumor tissue and its involvement in tumor development and proliferation. Potential clinical application of Gal-3-targeted inhibitors is often complicat...

Full description

Saved in:
Bibliographic Details
Published in:J Nanobiotechnology
Main Authors: Bojarová, P., Tavares, M. R., Laaf, D., Bumba, L., Petrásková, L., Konefał, R., Bláhová, M., Pelantová, H., Elling, L., Etrych, T., Chytil, P., Křen, V.
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6146777/
https://ncbi.nlm.nih.gov/pubmed/30236114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-018-0399-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items